Two Sigma Investments LP Sells 5,470 Shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR)

Two Sigma Investments LP reduced its holdings in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 21.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 20,231 shares of the company’s stock after selling 5,470 shares during the quarter. Two Sigma Investments LP owned 0.11% of Nature’s Sunshine Products worth $297,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of NATR. Millennium Management LLC acquired a new position in shares of Nature’s Sunshine Products during the fourth quarter worth about $1,135,000. Deutsche Bank AG acquired a new position in shares of Nature’s Sunshine Products during the fourth quarter worth about $103,000. Bridgeway Capital Management LLC boosted its position in shares of Nature’s Sunshine Products by 24.1% during the fourth quarter. Bridgeway Capital Management LLC now owns 17,514 shares of the company’s stock worth $257,000 after buying an additional 3,400 shares during the period. Bank of America Corp DE boosted its position in shares of Nature’s Sunshine Products by 12.2% during the fourth quarter. Bank of America Corp DE now owns 30,449 shares of the company’s stock worth $446,000 after buying an additional 3,312 shares during the period. Finally, BNP Paribas Financial Markets boosted its position in shares of Nature’s Sunshine Products by 346.9% during the fourth quarter. BNP Paribas Financial Markets now owns 11,719 shares of the company’s stock worth $172,000 after buying an additional 9,097 shares during the period. 79.40% of the stock is currently owned by institutional investors.

Nature’s Sunshine Products Stock Performance

Shares of NASDAQ NATR opened at $14.30 on Wednesday. The stock has a 50 day moving average price of $13.19 and a 200 day moving average price of $14.04. Nature’s Sunshine Products, Inc. has a 52 week low of $10.81 and a 52 week high of $18.06. The stock has a market capitalization of $262.42 million, a PE ratio of 16.25 and a beta of 1.16.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.16 by $0.09. Nature’s Sunshine Products had a return on equity of 11.08% and a net margin of 3.81%. The firm had revenue of $113.25 million during the quarter, compared to analysts’ expectations of $109.39 million.

Analyst Upgrades and Downgrades

Separately, DA Davidson reaffirmed a “buy” rating and set a $19.00 price objective on shares of Nature’s Sunshine Products in a research report on Tuesday, June 3rd.

Nature’s Sunshine Products Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.